These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7494038)

  • 1. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae.
    Godzik KL; O'Brien ER; Wang SK; Kuo CC
    J Clin Microbiol; 1995 Sep; 33(9):2411-4. PubMed ID: 7494038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells.
    Gaydos CA; Summersgill JT; Sahney NN; Ramirez JA; Quinn TC
    Infect Immun; 1996 May; 64(5):1614-20. PubMed ID: 8613369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae.
    Maass M; Gieffers J; Solbach W
    Herz; 2000 Mar; 25(2):68-72. PubMed ID: 10829241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells.
    Quinn TC; Gaydos CA
    Am Heart J; 1999 Nov; 138(5 Pt 2):S507-11. PubMed ID: 10539860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s).
    Coombes BK; Mahony JB
    Infect Immun; 1999 Jun; 67(6):2909-15. PubMed ID: 10338498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis.
    Hirono S; Pierce GN
    Mol Cell Biochem; 2003 Apr; 246(1-2):91-5. PubMed ID: 12841348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model.
    Rupp J; Koch M; van Zandbergen G; Solbach W; Brandt E; Maass M
    FEMS Microbiol Lett; 2005 Jan; 242(2):203-8. PubMed ID: 15621438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue.
    Ouchi K; Fujii B; Kudo S; Shirai M; Yamashita K; Gondo T; Ishihara T; Ito H; Nakazawa T
    J Infect Dis; 2000 Jun; 181 Suppl 3():S441-3. PubMed ID: 10839733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae and atherosclerosis.
    Ouchi K
    Jpn J Infect Dis; 1999 Dec; 52(6):223-7. PubMed ID: 10738358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydophila pneumoniae. Mechanisms of target cell infection and activation.
    Krüll M; Maass M; Suttorp N; Rupp J
    Thromb Haemost; 2005 Aug; 94(2):319-26. PubMed ID: 16113821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis.
    Coombes BK; Chiu B; Fong IW; Mahony JB
    J Infect Dis; 2002 Jun; 185(11):1621-30. PubMed ID: 12023768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth in vascular cells and cytokine production by Chlamydia pneumoniae.
    Gaydos CA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S473-8. PubMed ID: 10839742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.
    Di Pietro M; Filardo S; De Santis F; Sessa R
    Int J Mol Sci; 2013 Jul; 14(7):15105-20. PubMed ID: 23877837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The resistance of human monocyte-derived macrophages to Chlamydia pneumoniae infection is enhanced by interferon-gamma.
    Airenne S; Surcel HM; Bloigu A; Laitinen K; Saikku P; Laurila A
    APMIS; 2000 Feb; 108(2):139-44. PubMed ID: 10737459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of Chlamydia pneumoniae with human endothelial cells.
    Summersgill JT; Molestina RE; Miller RD; Ramirez JA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S479-82. PubMed ID: 10839743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae and vascular disease: an update.
    Mussa FF; Chai H; Wang X; Yao Q; Lumsden AB; Chen C
    J Vasc Surg; 2006 Jun; 43(6):1301-7. PubMed ID: 16765261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae.
    Leinonen M
    Eur Heart J; 1993 Dec; 14 Suppl K():57-61. PubMed ID: 8131790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells.
    Molestina RE; Miller RD; Lentsch AB; Ramirez JA; Summersgill JT
    Infect Immun; 2000 Jul; 68(7):4282-8. PubMed ID: 10858246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60.
    Hirono S; Dibrov E; Hurtado C; Kostenuk A; Ducas R; Pierce GN
    Circ Res; 2003 Oct; 93(8):710-6. PubMed ID: 14500333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chlamydia pneumoniae--chronic infection and atherosclerosis].
    Tiran B
    Wien Med Wochenschr; 2001; 151(24):590-3. PubMed ID: 11820175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.